PAF-induced Airways Hyperreactivity Is Modulated by Mast Cells in Mice

American Journal of Respiratory Cell and Molecular Biology

Volumn 14, Issue 5, 1996, Pages 461-469

  Longphre, Malinda ^a,b   Zhang, Liu Yi ^a   Paquette, Nicole ^a   Kleeberger, Steven R ^a  

^a The Johns Hopkins University   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; APAFANT; AZEPINE DERIVATIVE; EVANS BLUE; NEDOCROMIL; PROSTAGLANDIN D2; THROMBOCYTE ACTIVATING FACTOR; TRIAZOLE DERIVATIVE;

AKR MOUSE; ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BLOOD CELL COUNT; BONE MARROW TRANSPLANTATION; BRONCHUS; BRONCHUS HYPERREACTIVITY; CHEMISTRY; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; HEMATOCRIT; LUNG; LUNG LAVAGE; MALE; MAST CELL; MOUSE; MOUSE MUTANT; PATHOPHYSIOLOGY; PERMEABILITY; PHYSIOLOGY; SPECIES DIFFERENCE; TRACHEA;

ACETYLCHOLINE; ANALYSIS OF VARIANCE; ANIMALS; AZEPINES; BLOOD CELL COUNT; BONE MARROW TRANSPLANTATION; BRONCHI; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; EVANS BLUE; HEMATOCRIT; LUNG; MALE; MAST CELLS; MICE; MICE, INBRED AKR; MICE, MUTANT STRAINS; NEDOCROMIL; PERMEABILITY; PLATELET ACTIVATING FACTOR; PROSTAGLANDIN D2; SPECIES SPECIFICITY; TRACHEA; TRIAZOLES;

EID: 0030138017     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.14.5.8624251     Document Type: Article

References (52)

1. Ou, M. C., J. Kambayashi, T. Kawasaki, Y. Uemura, K. Shinozaki, E. Shiba, M. Sakon, M. Yukawa, and T. Mori. 1994. Potential etiologic role of PAF in two major septic complications: disseminated intravascular coagulation and multiple organ failure. Thombosis Res. 73:227-238.
2. Corcoran, P. C., T. Wang, N. M. Katz, J. D. St. Louis, M. L. Foegh, S. S. Rajan, A. R. Analouei, and R. B. Wallace. 1992. Platelet activating factor antagonist enhances lung preservation. J. Surg. Res. 52:615-620.
3. Henson, P. M., P. J. Barnes, and S. P. Banks-Schlegel. 1992. Platelet-activating factor: role in pulmonary injury and dysfunction and blood abnormalities. Am. Rev. Respir. Dis. 145:726-731.
4. Kurosawa, M., T. Yamashita, F. Kurimoto. 1994. Increased levels of blood platelet-activating factor in bronchial asthmatic patients with active symptoms. Allergy 49:60-63.
5. Chung, K. F. 1992. Platelet-activating factor in inflammation and pulmonary disorders. Clin. Sci. 83:127-138.
6. Evangelou, A. M. 1994. Platelet activating factor (PAF): Implications for coronary heart and vascular diseases. Prost. Leuk. Essent. Fatty Acids 50:1-28.
7. Chung, K. F., H. Aizawa, G. D. Leikauf, I. F. Ueki, T. W. Evans, and J. A. Nadel. 1986. Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation. J. Pharmacol. Exp. Ther. 236:580-584.
8. Kirsch, C. M., J. J. Brokaw, D. M. Prow, and G. W. White. 1992. Mechanism of platelet activating factor-induced vascular leakage in the rat trachea. Exp. Lung Res. 18:447-459.
9. Galli, S. J. 1993. New concepts about the mast cell. N. Engl. J. Med. 328:257-265.
10. M. M. Kaliner, and D. D. Metcalfe, editors. 1993. The Mast Cell in Health and Disease. Marcel Dekker, New York.
11. Schulman, E. S. 1993. The role of mast cells in inflammatory responses in the lung. Crit. Rev. Immunol. 13:35-70.
12. Martin, T. R., T. Takeishi, H. R. Katz, K. F. Austen, J. M. Drazen, and S. J. Galli. 1993. Mast cell activation enhances airway responsiveness to methacholine in the mouse. J. Clin. Invest. 91:1176-1182.
13. Sckizawa, K., G. H. Caughey, S. C. Lazarus, W. M. Gold, and J. A. Nadel. 1989. Mast cell tryptase causes airway smooth muscle hyperresponsiveness in dogs. J. Clin. Invest. 83:175-179.
14. Schwartz, L. B. 1987. Mediators of human mast cells and human mast cell subsets. Ann. Allergy 58:226-237.
15. DiMaria, G. U., S. Bellotiore, N. Ciancio, F. Ruggieri, and A. Mistretta. 1992. Nedocromil sodium inhibits the increase in airway reactivity induced by platelet activating factor in humans. Chest 102:123-128.
16. Hayes, J. P., K. F. Chung, and P. J. Barnes. 1992. Attenuation of platelet activating factor induced bronchoconstriction by nedocromil sodium. Eur. Respir. J. 5:1193-1196.
17. Mustafa, S. B. and F. L. Pearce. 1992. Histamine secretion from mast cells stimulated with platelet activating factor (PAF). Agents Actions (Special Conference Issue):C265-C267.
18. Longphre, M. and S. R. Kleeberger. 1995. Susceptibility to PAF-induced airways hyperreactivity and hyperpermeability: interstrain variation and genetic control. Am. J. Respir. Cell Mol. Biol. 13:586-594.
19. Kleeberger, S. R., J. E. Seiden, R. C. Levitt, and L.-Y. Zhang. 1993. Mast cells modulate acute ozone-induced inflammation of the murine lung. Am. Rev. Respir. Dis. 148:1284-1291.
20. Levitt, R. C. and W. Mitzner. 1988. Expression of airways hyperreactivity to acetylcholine as a simple autosomal recessive trait in mice. FASEB J. 2:2605-2608.
21. Houlihan, W. J. 1993. Platelet activating factor antagonists. In Platelet Activating Factor in Endotoxin and Immune Diseases. D. A. Handley, R. N. Saunders, W. J. Houlihan, and J. C. Tomesch, editors. Marcel Dekker, New York.
22. Casals-Stenzel, J., G. Muacevic and K.-H. Weber. 1987. Pharmacologic actions of WEB 2086, a new specific antagonist for platelet activating factor. J. Pharmacol. Exp. Ther. 241:974-981.
23. Braquet, P. 1991. Handbook of PAF and PAF Receptor Antagonists. CRC Press, Boca Raton, FL.
24. 3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists. Lipids 27:582-586.
25. Zar, J. H. 1984. Biostatistical Analysis, 2nd Ed. Prentice-Hall, Englewood Cliffs, NJ.
26. Ramos, B. F., Y. Zhang, R. Qureshi, and B. A. Jakschik. 1991. Mast cells are critical for the production of leukotrienes responsible for neutrophil recruitment in immune complex-induced peritonitis in mice. J. Immunol. 147:1636-1641.
27. Rao, T. S., A. F. Shaffer, J. L. Currie, and P. C. Isakson. 1994. Role of mast cells in calcium ionophore (A23187)-induced peritoneal inflammation in mice. Inflammation 18:187-192.
28. Martin, T. R., S. J. Galli, I. M. Katona, and J. M. Drazen. 1989. Role of mast cells in anaphylaxis. Evidence for the importance of mast cells in the cardiopulmonary alterations and death induced by anti-IgE in mice. J. Clin. Invest. 83:1375-1383.
29. Ishida, K. and Y. Fukuchi. 1992. The effect of ageing on airway responsiveness. Jpn. J. Thorac. Dis. 30:182-186.
30. Southgate, W. M., B. E. Pichoff, E. L. Stevens, V. Balaraman, C. F. Uyehara, and K. T. Nakamura. 1993. Ontogeny of epithelial modulation of airway smooth muscle function in the guinea pig. Pediatr. Pulmonol. 15:105-110.
31. Yarkony, K. A. and M. Wills-Karp. 1993. The effects of ageing on airway hyperreactivity in inbred strains of mice. Am. Rev. Respir. Dis. 147: A419. (Abstr.)
32. Sears, M. 1994. Growing up with asthma. BMJ 309:72-73.
33. 2. Prostaglandins 35:277-300.
34. 2 generation after activation of rat and human mast cells with anti-IgE. J. Immunol. 129:1627-1631.
35. Martin, T. R., N. P. Gerard, S. J. Galli, and J. M. Drazen. 1988. Pulmonary responses to bronchoconstrictor agonists in the mouse. J. Appl. Physiol. 64:2318-2323.
36. Columbo, M., E. M. Horowitz, J. McKenzie-White, A. Kagey-Sobotka, L. M. Lichtenstein. 1993. Pharmacologic control of histamine release from human basophils induced by platelet-activating factor. Int. Arch. Allergy Immunol. 102:383-390.
37. Louis, R., T. Bury, J.-L. Corhay, and M. F. Radermecker. 1994. Potentiation of histamine release from human leucocytes by PAF. Agents Actions 41:5-10.
38. Scodras, J. M., K. J. Betteridge, B. A. Croy, I. B. Johnstone and D. Rieger. 1991. Failure to detect platelet-activating factor using the splenectomized mouse bioassay. J. Reprod. Fertil. 92:483-494.
39. Brokaw, J. J., D. M. Prow, C. M. Kirsch, and G. W. White. 1991. Effects of platelet activating factor on vascular permeability and granulocyte recruitment in the rat trachea. Lung 169:109-119.
40. Vasquez-Bravo, Y. L. A. R., M. Russo, and S. Jancar. 1993. Differential sensitivity of mouse strains to platelet activating factor-induced vasopermeability and mortality: effect of antagonists. J. Lipid Med. 8:135-144.
41. Cavanah, D. K. and T. B. Casale. 1993. Histamine. In The Mast Cell in Health and Disease, M. A. Kaliner and D. D. Metcalfe, editors. Marcel Dekker, New York. 321-342.
42. Niimi, N., N. Noso, and S. Yamamoto. 1992. The effect of histamine on cultured endothelial cells. A study of the mechanism of increased vascular permeability. Eur. J. Pharmacol. 221:325-331.
43. Tokuyama, K., J. O. Lotvall, P. J. Barnes, and K. F. Chung. 1991. Mechanism of airway narrowing by inhaled platelet-activating factor: role of airway microvascular leakage. Am. Rev. Respir. Dis. 143:1345-1349.
44. Christie, P. E., J. P. Arm, and T. H. Lee. 1993. Leukotrienes. In The Mast Cell in Health and Disease. M. A. Kaliner and D. D. Metcalfe, editors. Marcel Dekker, New York. 321-342.
45. 4. Prostaglandins Leukotrienes Med. 6:153-159.
46. Casale, T. B. 1993. Acute effects of in vitro mast cell degranulation on human lung muscarinic receptors. Am. Rev. Respir. Dis. 147:940-945.
47. Venable, M. E., G. A. Zimmerman, T. M. McIntyre, and S. M. Prescott. 1993. Platelet activating factor: a phospholipid autocoid with diverse actions. J. Lipid Res. 34:691-702.
48. Gebremichael, I. and P. Leuenberger. 1992. Platelet-activating factor does not induce bronchial hyperreactivity in nonasthmatic subjects. Respiration 59:193-196.
49. Laitinen, A. and L. A. Laitinen. 1994. Pathology of asthma. Allergy Proc. 15:323-328.
50. Hozawa, S., Y. Haruta, S. Ishioka, and M. Yamakido. 1995. Effects of PAF antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma. Am. J. Respir. Crit. Care Med. 152:1198-1202.
51. Kuitert, L. K. Hui, S. Uthayarkumar, W. Burke, A. C. Newland, S. Uden, and N. C. Barnes. 1993. Effect of the platelet-activating factor antagonist UK-74505 on the early and late response to allergen. Am. Rev. Respir. Dis. 147:82-86.
52. Freitag, A., R. M. Watson, G. Matsos, C. Eastwood, and P. M. O'Byrne. 1993. Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses. Thorax 48:594-598.